Paclitaxel-eluting stents for treatment of coronary artery disease
Record ID 32011000901
English
Authors' objectives:
The paclitaxel-eluting coronary stent is a device/drug combination product consisting of a coronary stent system and the drug, paclitaxel, impregnated in a polymer coating. The paclitaxel-eluting stent is used for the minimally invasive treatment of coronary artery obstruction in patients with symptomatic coronary artery disease who require percutaneous coronary angioplasty and stenting. Paclitaxel is an antineoplastic drug which is released gradually into the arterial wall to suppress scar tissue formation within the stent and adjacent areas.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11867
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Coronary Artery Disease
- Paclitaxel
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.